Compound Detail
CHEMBL4162951
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCC(C)[C@@H]1C(=O)/C(=C(/O)[C@@H]2[C@@H]3[C@H](C)C[C@H](C)C[C@@H]3C=C[C@@H]2[C@]2(C)O[C@H]2C)C(=O)N1C
Basic Information
| ChEMBL ID | CHEMBL4162951 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NPWKEUKXVOMELT-CTIINMITSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
429.6
MW (Da)
4.53
ALogP
4
HBA
1
HBD
70.1
PSA (Ų)
0.23
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29901398 | 10.1021/acs.jmedchem.8b00494 | Retinoic acid receptor RXR-alpha | 1 |
| 29901398 | 10.1021/acs.jmedchem.8b00494 | Retinoic acid receptor RXR-beta | 1 |
| 29901398 | 10.1021/acs.jmedchem.8b00494 | Retinoic acid receptor RXR-gamma | 1 |
Data from ChEMBL 36 via Core Engine